CHMP afgjorde derfor, at fordelene ved Cyanokit opvejer risiciene til behandling af kendt eller formodet cyanidforgiftning.
Therefore, the CHMP decided that Cyanokit’ s benefits are greater than its risks for the treatment of known or suspected cyanide poisoning.